|
Sep 8
|
MacroGenics Announces TAMARACK Phase 2 Data Presentation at ESMO Congress 2024
|
|
Jul 7
|
MacroGenics Insider Ups Holding By 83% During Year
|
|
Jun 11
|
MacroGenics to Participate in Upcoming Investor Conference
|
|
May 12
|
US$15.10: That's What Analysts Think MacroGenics, Inc. (NASDAQ:MGNX) Is Worth After Its Latest Results
|
|
May 10
|
Macrogenics Stock Drops 77% After Study Deaths
|
|
May 10
|
Macrogenics Inc (MGNX) Q1 2024 Earnings: Misses Revenue Estimates Amidst Ongoing Clinical ...
|
|
May 10
|
MacroGenics, Inc. (NASDAQ:MGNX) Q1 2024 Earnings Call Transcript
|
|
May 10
|
MacroGenics (MGNX) Q1 2024 Earnings Call Transcript
|
|
May 9
|
MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim TAMARACK Phase 2 Study Data
|
|
May 3
|
MacroGenics Announces Date of First Quarter 2024 Financial Results Conference Call
|
|
Apr 19
|
We're Hopeful That MacroGenics (NASDAQ:MGNX) Will Use Its Cash Wisely
|
|
Apr 3
|
MacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures
|
|
Mar 14
|
MacroGenics, Inc. (NASDAQ:MGNX) Q4 2023 Earnings Call Transcript
|
|
Mar 9
|
12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds
|
|
Mar 8
|
Q4 2023 MacroGenics Inc Earnings Call
|
|
Mar 8
|
MacroGenics (MGNX) Q4 2023 Earnings Call Transcript
|
|
Mar 8
|
Macrogenics Inc (MGNX) Reports Strong Financial Position and Advancements in Cancer Treatment ...
|
|
Mar 7
|
MacroGenics (MGNX) Reports Q4 Loss, Lags Revenue Estimates
|
|
Mar 7
|
MacroGenics Provides Update on Corporate Progress and 2023 Financial Results
|
|
Mar 7
|
Insider Sell: COO Eric Risser Sells 41,159 Shares of Macrogenics Inc (MGNX)
|